These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24615157)

  • 1. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
    Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
    Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.
    Isayev O; Rausch V; Bauer N; Liu L; Fan P; Zhang Y; Gladkich J; Nwaeburu CC; Mattern J; Mollenhauer M; Rückert F; Zach S; Haberkorn U; Gross W; Schönsiegel F; Bazhin AV; Herr I
    Oncotarget; 2014 Jul; 5(13):5177-89. PubMed ID: 25015789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
    Rausch V; Liu L; Kallifatidis G; Baumann B; Mattern J; Gladkich J; Wirth T; Schemmer P; Büchler MW; Zöller M; Salnikov AV; Herr I
    Cancer Res; 2010 Jun; 70(12):5004-13. PubMed ID: 20530687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
    Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide inhibits CD133
    Acikgoz E; Tatar C; Oktem G
    J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide-induced in vitro and in vivo cytotoxicity in human breast cancer stem cells and primary breast cancer cells.
    Li J; Liu R; Yang Y; Huang Y; Li X; Liu R; Shen X
    Oncol Rep; 2014 May; 31(5):2181-6. PubMed ID: 24676587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of hypoxia induction in an in vivo animal replacement model for experimental evaluation of pancreatic cancer.
    Bauer N; Liu L; Aleksandrowicz E; Herr I
    Oncol Rep; 2014 Jul; 32(1):153-8. PubMed ID: 24842335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation.
    MacKenzie TN; Mujumdar N; Banerjee S; Sangwan V; Sarver A; Vickers S; Subramanian S; Saluja AK
    Mol Cancer Ther; 2013 Jul; 12(7):1266-75. PubMed ID: 23635652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines.
    Liu Y; Cui YF
    Asian Pac J Cancer Prev; 2013; 14(9):5243-8. PubMed ID: 24175808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
    Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
    Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK
    J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.
    Rausch V; Liu L; Apel A; Rettig T; Gladkich J; Labsch S; Kallifatidis G; Kaczorowski A; Groth A; Gross W; Gebhard MM; Schemmer P; Werner J; Salnikov AV; Zentgraf H; Büchler MW; Herr I
    J Pathol; 2012 Jul; 227(3):325-35. PubMed ID: 22262369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
    Wang H; Ma D; Wang C; Zhao S; Liu C
    Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.
    Han D; Wu G; Chang C; Zhu F; Xiao Y; Li Q; Zhang T; Zhang L
    Oncotarget; 2015 Dec; 6(38):40907-19. PubMed ID: 26517513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
    Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
    Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
    PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.
    Kallifatidis G; Labsch S; Rausch V; Mattern J; Gladkich J; Moldenhauer G; Büchler MW; Salnikov AV; Herr I
    Mol Ther; 2011 Jan; 19(1):188-95. PubMed ID: 20940707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.